211 related articles for article (PubMed ID: 18782432)
21. Venous thromboembolic risk and its prevention in hospitalized medical patients.
Haas SK
Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism: identifying patients at risk and establishing prophylaxis.
Shirvanian S; Tapson VF
Curr Med Res Opin; 2015 Dec; 31(12):2297-311. PubMed ID: 26414590
[TBL] [Abstract][Full Text] [Related]
23. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
24. An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.
Samama MM; Kleber FX
Thromb J; 2006 Jul; 4():8. PubMed ID: 16817957
[TBL] [Abstract][Full Text] [Related]
25. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.
Dolovich LR; Ginsberg JS; Douketis JD; Holbrook AM; Cheah G
Arch Intern Med; 2000 Jan; 160(2):181-8. PubMed ID: 10647756
[TBL] [Abstract][Full Text] [Related]
27. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
Wharin C; Tagalakis V
Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
[TBL] [Abstract][Full Text] [Related]
28. Overview of venous thromboembolism.
Abad Rico JI; Llau Pitarch JV; Rocha E
Drugs; 2010 Dec; 70 Suppl 2():3-10. PubMed ID: 21162604
[TBL] [Abstract][Full Text] [Related]
29. Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues.
Muntz J
Am J Surg; 2010 Sep; 200(3):413-21. PubMed ID: 20409525
[TBL] [Abstract][Full Text] [Related]
30. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
Turpie AG; Norris TM
Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
[TBL] [Abstract][Full Text] [Related]
31. What has changed in venous thromboembolism prophylaxis for hospitalized patients over recent decades: review article.
Raymundo SRO; Lobo SMA; Hussain KMK; Hussein KG; Secches IT
J Vasc Bras; 2019; 18():e20180021. PubMed ID: 31191626
[TBL] [Abstract][Full Text] [Related]
32. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
33. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
Daskalopoulos ME; Daskalopoulou SS; Liapis CD
Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
[TBL] [Abstract][Full Text] [Related]
34. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
35. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
Liapis CD; Daskalopoulos ME; Daskalopoulou SE
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561
[TBL] [Abstract][Full Text] [Related]
36. Asian venous thromboembolism guidelines: prevention of venous thromboembolism.
Liew NC; Chang YH; Choi G; Chu PH; Gao X; Gibbs H; Ho CO; Ibrahim H; Kim TK; Kritpracha B; Lee LH; Lee L; Lee WY; Li YJ; Nicolaides AN; Oh D; Pratama D; Ramakrishnan N; Robless PA; Villarama-Alemany G; Wong R;
Int Angiol; 2012 Dec; 31(6):501-16. PubMed ID: 23222928
[TBL] [Abstract][Full Text] [Related]
37. Management of venous thromboembolism in the elderly.
Spyropoulos AC; Merli G
Drugs Aging; 2006; 23(8):651-71. PubMed ID: 16964988
[TBL] [Abstract][Full Text] [Related]
38. Low-molecular-weight heparin in oncology.
Zacharski LR; Loynes JT
Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
[TBL] [Abstract][Full Text] [Related]
39. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study.
Vallano A; Arnau JM; Miralda GP; Pérez-Bartolí J
Thromb J; 2004 Apr; 2(1):3. PubMed ID: 15059286
[TBL] [Abstract][Full Text] [Related]
40. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
Lewis TC; Cortes J; Altshuler D; Papadopoulos J
J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
